Exane Derivatives’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Exane Derivatives's JNJ Position: Q2 2022 in Review
Exane Derivatives increased its Johnson & Johnson (JNJ) stake by 88% in Q2 2022, buying an estimated $885K and bringing the position to 10,612 shares worth $1.88M. The position accounts for 1.08% of the portfolio, ranked #18.
Exane Derivatives first reported a position in JNJ in Q4 2014 and has held it in 17 quarters since. The position peaked at $2.29M in Q1 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.
- Exane Derivatives held 10,612 shares of Johnson & Johnson worth $1.88M as of Q2 2022.
- Exane Derivatives bought 4,965 Johnson & Johnson shares in Q2 2022, an estimated $885K.
- Johnson & Johnson made up 1.08% of Exane Derivatives's portfolio in Q2 2022, its #18 holding.
- Exane Derivatives first reported a position in Johnson & Johnson in Q4 2014 and has held it in 17 quarters since.
- Exane Derivatives's Johnson & Johnson position peaked at $2.29M in Q1 2021.
- 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.